The Medicines and Healthcare products Regulatory Agency (MHRA) has today approved  GSK's Lynavoy (linerixibat) for use to ...

Cambridge, USA-based biotech Moderna today reported financial results and provided business updates for the first quarter of ...

Over 500 new drugs are expected to be introduced to the Russian market this year, including through localization, according ...

Hemab Therapeutics Holdings, a Phase III-ready biotech developing blood coagulation disorder treatments, has announced terms ...

USA-based Pinnaql has acquired Pharma Resource Group (PRG), a provider of analytical sciences, formulation, scientific ...

Oncologic Drugs Advisory Committee (ODAC) has recognized a favorable benefit risk profile for AstraZeneca’s Truqap ...

US biotech Alector has discontinued development of its Alzheimer’s disease candidate nivisnebart after an interim analysis ...

US biotech Axsome Therapeutics (Nasdaq: AXSM) has secured US regulator approval for Auvelity (dextromethorphan hydrobromide ...

US biotech Cue Biopharma has set out a three-part reset, appointing Shao-Lee Lin as chief executive, licensing a ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Aspaveli (pegcetacoplan) to treat patients ...

US biotech major Amgen late yesterday announced financial results for the first quarter of 2026, showing that revenues ...

British pharma AstraZeneca (LSE: AZN) has hit a regulatory wobble after a US Food and Drug Administration advisory panel ...